The author reflects on the mergers and acquisition of corporations (M&A) activity of the chemical industry in 2011. He mentions that PricewaterhouseCoopers LLP (PwC) has recorded a decline in deal-making for second quarter of 2011 due to the decline of numbers and value of the mega-deals. He also highlights the four mega-deals during the second quarter of 2011 including Solvay's offer of 4.7 billion dollars for France's Rhodia Corp. and the sales of Evonik's carbon to Rhone Capital LLC.